Isothermal Nucleic Acid Amplification Technology Market by Product (Assays, Kits, & Reagents, Systems), Type (Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification), Application, End-User - Glo

Isothermal Nucleic Acid Amplification Technology Market by Product (Assays, Kits, & Reagents, Systems), Type (Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification), Application, End-User - Global Forecast 2023-2030


The Isothermal Nucleic Acid Amplification Technology Market size was estimated at USD 3.35 billion in 2022 and expected to reach USD 3.77 billion in 2023, at a CAGR 13.48% to reach USD 9.22 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Isothermal Nucleic Acid Amplification Technology Market.
  • Based on Product, market is studied across Assays, Kits, & Reagents and Systems. The Assays, Kits, & Reagents commanded largest market share of 63.33% in 2022, followed by Systems.
  • Based on Type, market is studied across Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification, Strand Displacement Amplification, and Transcription-mediated Amplification. The Loop-mediated Isothermal Amplification commanded largest market share of 25.78% in 2022, followed by Nucleic Acid Sequence-based Amplification.
  • Based on Application, market is studied across Blood Screening and Infectious Disease Diagnosis. The Infectious Disease Diagnosis is further studied across CT/NG, Hepatitis, HIV, and Influenza. The Infectious Disease Diagnosis commanded largest market share of 56.12% in 2022, followed by Blood Screening.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Reference Laboratories. The Reference Laboratories commanded largest market share of 52.23% in 2022, followed by Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.33% in 2022, followed by Americas.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Isothermal Nucleic Acid Amplification Technology Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Isothermal Nucleic Acid Amplification Technology Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Isothermal Nucleic Acid Amplification Technology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AtilaBiosystems, Beijing SBS Genetech Co., Ltd., bioMérieux SA, Biosearch Technologies by LGC Limited, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Fortis Life Sciences, LLC, GENOMTEC S.A., GenoSensor Corporation, Grifols S.A., highQu GmbH, Hologic, Inc., Illumina, Inc., Jena Bioscience GmbH, Life Sciences Advanced Technologies, Inc., Mast Group Ltd., Meridian Bioscience Inc. by SD Biosensor, Inc., New England Biolabs, Inc., OptiGene Limited, PCR Biosystems Ltd., QIAGEN GmbH, Quidel Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Ustar Biotechnologies (Hangzhou) Ltd, Xiamen Jiqing Biomedical Technology Co., Ltd., Zhengzhou Laboao Instrument Equipment CO., LTD, and Zhuhai Biori Biotechnology Co., Ltd..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Isothermal Nucleic Acid Amplification Technology Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Isothermal Nucleic Acid Amplification Technology Market?
  3. What is the competitive strategic window for identifying opportunities in the Isothermal Nucleic Acid Amplification Technology Market?
  4. What are the latest technology trends and regulatory frameworks in the Isothermal Nucleic Acid Amplification Technology Market?
  5. What is the market share of the leading vendors in the Isothermal Nucleic Acid Amplification Technology Market?
  6. Which modes and strategic moves are suitable for entering the Isothermal Nucleic Acid Amplification Technology Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Isothermal Nucleic Acid Amplification Technology Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of antimicrobial and infectious diseases worldwide
5.1.1.2. Increasing adoption of INAAT for accurate & rapid testing results
5.1.1.3. Development of miniaturized nucleic acid-based diagnostics
5.1.2. Restraints
5.1.2.1. High cost of reagents and implementation of technology
5.1.3. Opportunities
5.1.3.1. Technological advancements in isothermal nucleic acid amplification
5.1.3.2. Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions
5.1.4. Challenges
5.1.4.1. Limitation of isothermal nucleic acid amplification technology
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Isothermal Nucleic Acid Amplification Technology Market, by Product
6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Systems
7. Isothermal Nucleic Acid Amplification Technology Market, by Type
7.1. Introduction
7.2. Helicase-dependent Amplification
7.3. Loop-mediated Isothermal Amplification
7.4. Nucleic Acid Sequence-based Amplification
7.5. Strand Displacement Amplification
7.6. Transcription-mediated Amplification
8. Isothermal Nucleic Acid Amplification Technology Market, by Application
8.1. Introduction
8.2. Blood Screening
8.3. Infectious Disease Diagnosis
8.4.1. CT/NG
8.4.2. Hepatitis
8.4.3. HIV
8.4.4. Influenza
9. Isothermal Nucleic Acid Amplification Technology Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals
9.4. Reference Laboratories
10. Americas Isothermal Nucleic Acid Amplification Technology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics
13.3.1.2. Medix Biochemica Acquires German MDx Raw Materials Producer MyPols Biotec
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Stilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for Oncology
13.3.2.2. Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
13.3.2.3. WeTrade and Jiqing Biomedical partner to sell monkeypox tests
13.3.3. New Product Launch & Enhancement
13.3.3.1. Recombinase Polymerase Amplification, or RPA, is the breakthrough, isothermal replacement to PCR
13.3.3.2. Mawi iSWAB Microbiome-EL Enables Prime Discoveries’ Development of Rapid Extraction-Less COVID Diagnostic Assay
13.3.3.3. Thermo Fisher introduces two RT-LAMP tests to detect viral pathogens
13.3.4. Investment & Funding
13.3.4.1. Polish biotech Genomtec raises EUR 2.9 million (USD 3.19 million) from share issue
13.3.4.2. Ankur Capital invests in molecular diagnostic startup D-NOME
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. AtilaBiosystems
14.1.3. Beijing SBS Genetech Co., Ltd.
14.1.4. bioMérieux SA
14.1.5. Biosearch Technologies by LGC Limited
14.1.6. DiaSorin S.p.A.
14.1.7. Eiken Chemical Co., Ltd.
14.1.8. Fortis Life Sciences, LLC
14.1.9. GENOMTEC S.A.
14.1.10. GenoSensor Corporation
14.1.11. Grifols S.A.
14.1.12. highQu GmbH
14.1.13. Hologic, Inc.
14.1.14. Illumina, Inc.
14.1.15. Jena Bioscience GmbH
14.1.16. Life Sciences Advanced Technologies, Inc.
14.1.17. Mast Group Ltd.
14.1.18. Meridian Bioscience Inc. by SD Biosensor, Inc.
14.1.19. New England Biolabs, Inc.
14.1.20. OptiGene Limited
14.1.21. PCR Biosystems Ltd.
14.1.22. QIAGEN GmbH
14.1.23. Quidel Corporation
14.1.24. Tecan Trading AG
14.1.25. Thermo Fisher Scientific Inc.
14.1.26. Ustar Biotechnologies (Hangzhou) Ltd
14.1.27. Xiamen Jiqing Biomedical Technology Co., Ltd.
14.1.28. Zhengzhou Laboao Instrument Equipment CO., LTD
14.1.29. Zhuhai Biori Biotechnology Co., Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings